It has been reported MEG3 inhibited tumor metastasis by regulating the Wnt/beta-catenin pathway in oral squamous cell carcinoma [69], regulating the expression of miR-21 in gastric cancer (GC) [70], and miR-183 expression in human pancreatic cancers [71]. The gene discussed is MEG3; the disease is gastric cancer.